Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Falko

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
The Ohio State Medical Journal|August 1, 1983
Ocular changes in Graves' diseaseJ Pizzino, J M Falko, J L Moses
Archives of Internal Medicine|March 1, 1982
The value of technetium Tc 99m pertechnetate thyroid scanning in the diagnosis of factitious thyrotoxicosisH Abdel-Nabi, J M Falko, J Olsen
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Unusual manifestations of cushing's syndrome in a multiple endocrine neoplasia type I kindredV Sundaram, D P Schuster, J M Falko
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type IIA H Chevinsky, J P Minton, J M Falko
The American Journal of the Medical Sciences|December 1, 1990
17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronismD A Cottrell, F A Bello, J M Falko
The American Journal of Digestive Diseases|June 1, 1975
Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstructionJ M Falko, H S Mekhjian, F B Thomas
The American Journal of Medicine|July 1, 1984
Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinomaK Osei, J M Falko, K P Nelson, et al.
The American Journal of the Medical Sciences|November 1, 1983
Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabeticsP Levin, J M Falko, T M O'Dorisio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1991
The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patientsF Bello, J M Falko, T M O'Dorisio, et al.
Annals of Internal Medicine|November 1, 1979
Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterolJ M Falko, J L Witztum, G Schonfeld, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
The Ohio State Medical Journal|August 1, 1983
Ocular changes in Graves' diseaseJ Pizzino, J M Falko, J L Moses
Archives of Internal Medicine|March 1, 1982
The value of technetium Tc 99m pertechnetate thyroid scanning in the diagnosis of factitious thyrotoxicosisH Abdel-Nabi, J M Falko, J Olsen
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Unusual manifestations of cushing's syndrome in a multiple endocrine neoplasia type I kindredV Sundaram, D P Schuster, J M Falko
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1990
Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type IIA H Chevinsky, J P Minton, J M Falko
The American Journal of the Medical Sciences|December 1, 1990
17 alpha-hydroxylase deficiency masquerading as primary hyperaldosteronismD A Cottrell, F A Bello, J M Falko
The American Journal of Digestive Diseases|June 1, 1975
Silent pancreatic pseudocyst. An unusual cause of extrahepatic biliary obstructionJ M Falko, H S Mekhjian, F B Thomas
The American Journal of Medicine|July 1, 1984
Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinomaK Osei, J M Falko, K P Nelson, et al.
The American Journal of the Medical Sciences|November 1, 1983
Limitations in usefulness of single dose intermediate acting insulin: a rapid response pattern in some type I diabeticsP Levin, J M Falko, T M O'Dorisio, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1991
The use of continuous subcutaneous octreotide infusion in brittle type 1 diabetic patientsF Bello, J M Falko, T M O'Dorisio, et al.
Annals of Internal Medicine|November 1, 1979
Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterolJ M Falko, J L Witztum, G Schonfeld, et al.
Pageof 8